Sign in

CIK 0001850270

  • Emerging growth company

PROKIDNEY CORP.

Sign in to watch
Ticker
PROK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Operating
EIN
981586514
Phone
+1 336-999-7028
Business address
2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
Former names
Social Capital Suvretta Holdings Corp. III
  1. 4 Planned sale SVP of Regulatory Development sold 17,238 shares at $2.50 ($43,095)
  2. 4 Planned sale SVP of Regulatory Development sold 84,403 shares at an average $1.73 ($146,005)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Conversion Chief Legal Officer acquired 81,928 shares (conversion)
  9. 4 Conversion SVP of Regulatory Development acquired 137,073 shares (conversion)
  10. 4 Conversion Director acquired 748,952 shares (conversion)
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market sale Former 10% Owner sold 7,256,367 shares at $1.31 ($9,498,584)
  13. 4 Open-market sale 10% owner sold 752,800 shares at an average $1.31 ($987,946)
  14. 4 Open-market sale 10% owner sold 576,700 shares at an average $1.56 ($897,872)
  15. 4 Open-market sale 10% owner sold 209,833 shares at an average $1.60 ($334,948)
  16. 4 Open-market sale 10% owner sold 405,400 shares at an average $1.70 ($688,100)
  17. 4 Conversion Director acquired 5,289,055 shares (conversion)
  18. 4 Open-market sale 10% owner sold 391,400 shares at an average $1.65 ($645,514)
  19. 4 Open-market sale 10% owner sold 321,473 shares at an average $1.77 ($567,573)
  20. 4 Open-market sale 10% owner sold 447,500 shares at an average $2.01 ($899,963)

Page 4 of 8 · 153 filings